Ep0162 50505 — Los Angeles, California

Ep0162 50505 is a clinical research site located in Los Angeles, California, United States 90095.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Ep0162 50505 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Stereotypical Prolonged Seizures.

Sponsors: UCB Biopharma SRL.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ep0162 50505?

Ep0162 50505 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ep0162 50505 conducted?

Ep0162 50505 has 1 clinical trials on record, with 1 currently active. Their work covers Stereotypical Prolonged Seizures.

Is Ep0162 50505 accredited by Crixeo Health?

Ep0162 50505 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Ep0162 50505?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.